Washington, DC 20006-5349
HELPLINE
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white blood cells that fight infection and illness, but cancer cells can sometimes trick the immune system. CAR T-cell therapy helps the body’s immune system see…
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with pemetrexed and platinum-based chemotherapy. Keytruda(pembrolizumab) is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help…
Mesothelioma has often been classified as a cancer that only affects older people, as the average age of diagnosis for pleural is 72 and peritoneal is 67. This assumption of advanced age being a factor has led to misdiagnosis among younger patients. The demographic of meso patients is consistently changing…
The Mesothelioma Applied Research Foundation is excited to announce its latest research grant recipients, awarding a total of $300,000. This brings the Foundation’s total funding…
One of the many services that the Meso Foundation offers to patients, caregivers, and the bereaved community is support groups offered over Zoom video conferencing.…
UPDATE: Deadline extended to November 17 at 11:59 PM ET. Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many…
Peritoneal mesothelioma can be treated surgically (i.e. HIPEC) and/or systemically (chemotherapy or immunotherapy). This session features two medical oncologists and three peritoneal mesothelioma surgeons as they discuss a number of case scenarios and considerations when choosing a treatment.This session features: Kiran Turaga, MD, Yale Andrew Blakeley, MD, NIHGarrett Nash, MD,…
In this episode, we interview Cristobal. After some concerning abdominal pain brought him to his doctor and started a chain reaction of tests, Cristobal’s diagnosis…
The Mesothelioma Applied Research Foundation will begin hosting a special support group for caregivers of mesothelioma patients, hosted by Lora Mosca and facilitated by Jennifer…
Mesothelioma community member, patient, and Meso Foundation’s board member, Jessica Blackford-Cleeton just concluded her participation in the review process for the Congressionally Directed Medical Research…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
